Determination of von Willebrand factor activity with collagen-binding assay and diagnosis of von Willebrand disease: Effect of collagen source and coating conditions

Journal of Laboratory and Clinical Medicine

Volumn 140, Issue 4, 2002, Pages 250-254

  Paczuski, Ryszard ^a,b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b KAZIMIERZ WIELKI UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036793055     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.127715     Document Type: Article

References (20)

1. Brown JE, Bosak JO. An ELISA test for binding of von Willebrand factor antigen to collagen. Thromb Res 1986;43:303-11.
2. Aihara M, Kimura A, Chiba Y, Yoshoda Y. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Thromb Haemost 1988;59:485-90.
3. Favaloro EJ. Collagen binding assay for von Willebrand factor (vWf:CBA): detection of Willebrand's disease (vWD) and discrimination of vWD subtypes depends on collagen source. Thromb Haemost 2000;83:127-35.
4. Favaloro EJ, Grispo L, Exner T, Koutts J. Development of simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and II, von Wilebrand's disease. Blood Coag Fibrinol 1991;2:285-91.
5. Fischer B, Thomas KB, Dorner F. A new method of immobilizing collagen onto plastic surfaces: measurement of von Willebrand factor collagen binding activity. Ann Hematol 1998;76(suppl 1):26.
6. Nichols WC, Ginsburg D. Von Willebrand disease. Medicine 1997;76:1-21.
7. Marder VJ, Manucci PM, Firkin BG. Hoyer LW, Meyer D. Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemostas 1985;54:871-2.
8. Sadler JE. Von Willebrand factor. J Biol Chem 1991;226:22777-80.
9. Falcon T, Caron C, Courtin P, Wurz A, Deghaye M, Bauteres F, et al. Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haematol 1992;80:488-94.
10. Soff GA. Autoantibody to von Willebrand factor in systemic lupus erythematosus. J Lab Clin Med 1993;121:424-30.
11. Ruggieri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1999;82:576-84.
12. Fujimoto T, Ohara S, Hawiger J. Thrombin-induced exposure and prostacylin inhibition of the receptor for factor VIII/vWf on human platelets. J Clin Invest 1982;69:1212-22.
13. Rand JH, Patel NU, Schwartz E, Zhou SL, Potter BJ. 150 kD von Willbrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 1991;88:253-9.
14. Santoro SA. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. Thromb Res 1981;21:689-93.
15. Skariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. Thrombin induced exposure and prostacylin inhibition of the receptor for factor VIII/vWf on human platelets. Br J Haematol 1986;63:681-91.
16. Takahashi Y, Kalafatis M, Girma JP, Sewerin K, Andersson LO, Meyer D. Localization of factor VIII binding domain on 34 kilodalton fragment of the N-terminal portion of von Willebrand factor. Blood 1987;70:1679-82.
17. Ginsburg D. Molecular genetics of von Willebrand disease. Thromb Haemost 1999;82:585-91.
18. Howard MA, Firkin BG. Ristocetin: a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971;26:362-9.
19. Falvarolo EJ. Sulfatide-binding assay for von Willebrand factor: detection of von Willebrand's disease without discrimination of vWD subtypes. Thromb Res 2000;98:213-9.
20. Falvarolo EJ, Henniker A, Facey D, Hertzberg M. Discrimination of von Willebrands disease (vWD) subtypes: direct comparison of von Willebrand factor: collagen binding assay (vWf: CBA) with monoclonal antibody (MAB) based vWf-capture systems. Thromb Haemost 2000;84:541-7.